Submit A Case
Home - Network - Working Groups - Rare Disease Working Groups - CADASIL, Moyamoya (NEUROVASC-WG) - Clinical Decision Support Tools - Clinical Practice Guidelines (CPGs) adopted
CADASIL, Moyamoya (NEUROVASC-WG)
Introduction Diseases covered
Expert & Centers
Experts Centers
Clinical Decision Support Tools
Patient Pathways Do’s and Don’ts Clinical Practice Guidelines (CPGs) adopted Clinical Expert Consensus Statements Written Clinical Outcome Measures
Registry
Research
Clinical Trials/Observational Studies Research Publications
Training and Education
E-Learning Pills of Knowledge (PoK) Webinars

Clinical Practice Guidelines (CPGs) adopted

The Neurovascular Diseases Working Group (NEUROVASC-WG) follows (and have generated) existing (national and international) guidelines. The guidelines reflect the latest scientific evidence and are regularly reviewed and updated to ensure they remain up-to-date.

Result (1)
European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)
February 02 2023

Bersano A, Khan N, Fuentes B, Acerbi F, Canavero I, Tournier-Lasserve E, Vajcoczy P, Zedde ML, Hussain S, Lémeret S, Kraemer M, Herve D. European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN). Eur Stroke J. 2023 Mar;8(1):55-84. doi: 10.1177/23969873221144089. Epub 2023 Feb 2. PMID: 37021176; PMCID: PMC10069176.

Skip to content